SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.73
+$0.49 (+1.52%)
Nov 2, 2026, 10:38 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 341K | 318K | 216.73K | n/a |
Gross Profit | -341K | -318K | -216.73K | n/a |
Operating Income | -21.97M | -15.41M | -13.63M | -11.1M |
Interest Income | 2.1M | 1.59M | 1.07M | 1.29M |
Pretax Income | -19.86M | -13.82M | -12.56M | -9.82M |
Net Income | -19.86M | -13.82M | -12.56M | -9.82M |
Selling & General & Admin | 11.01M | 6.85M | 5.92M | 3.01M |
Research & Development | 10.62M | 8.24M | 7.71M | 8.09M |
Other Expenses | n/a | n/a | -216.73K | n/a |
Operating Expenses | 21.63M | 15.09M | 13.41M | 11.1M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 21.97M | 15.41M | 13.63M | 11.1M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 33.44M | 19.93M | 33.43M | 33.43M |
Shares Outstanding (Diluted) | 33.44M | 19.93M | 33.43M | 33.43M |
EPS (Basic) | -0.59 | -0.69 | -0.38 | n/a |
EPS (Diluted) | -0.59 | -0.69 | -0.38 | n/a |
EBITDA | -21.63M | -13.5M | -12.34M | -10.96M |
EBIT | -21.97M | -13.82M | -12.56M | -11.1M |
Depreciation & Amortization | 341K | 318K | 216.73K | 137.27K |
Add to Watchlist
Select watchlists to add or remove SGP